Your logo

Prostate News Archive


  • Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer ... (Business Wire via Yahoo! Finance)

    CHICAGO----Investigators of a recent multi-institutional trial, led by principal investigator Bradley Prestidge, conclude that Cesium-131, a medical isotope used in low dose brachytherapy treatment for prostate cancer, "... has come into widespread use; and the clinical results of this trial are mature enough to be of immediate, important, practical use to practitioners."

  • The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With ... (Medical News Today) Nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment according to a report by Dr. Oh and colleagues in the online version of Cancer.ZA is an intravenous bisphosphonate given to decrease skeletal related events in CaP patients with bone metastases. [click link for full article]

  • For Men, a Saving Surgery: Twenty-Five Years Ago, Patrick C. Walsh Devised a Prostate-Cancer Operation That Allowed ... (RedNova)

    By Marie McCullough, The Philadelphia Inquirer Apr. 30--In 1982, the surgical cure for prostate cancer was considered worse than the disease. Removing the prostate meant life-threatening bleeding, guaranteed impotence, and a 1 in 4 chance of incontinence.

  • Women 'more distressed by prostate cancer' (Perth Now)

    WOMEN are more distressed by prostate cancer than their male partners who are diagnosed with the disease, a study has found.

  • Back to Prostate News Archive